RegenETP, Inc. (RGTPQ)
OTCMKTS
· Delayed Price · Currency is USD
0.1600
0.00 (0.00%)
Apr 3, 2025, 4:00 PM EST
RegenETP Revenue
RegenETP had revenue of $73.00K in the twelve months ending March 31, 2023, down -98.66% year-over-year. In the year 2022, RegenETP had annual revenue of $814.00K, down -91.34%.
Revenue (ttm)
73.00K
Revenue Growth
-98.66%
P/S Ratio
17.54
Revenue / Employee
1.70K
Employees
43
Market Cap
1.17M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2022 | 814.00K | -8.59M | -91.34% |
| Dec 31, 2021 | 9.40M | -722.00K | -7.13% |
| Dec 31, 2020 | 10.13M | 4.47M | 79.16% |
| Dec 31, 2019 | 5.65M | 1.61M | 39.97% |
| Dec 31, 2018 | 4.04M | 2.48M | 158.35% |
| Oct 31, 2018 | Pro | Pro | Pro |
| Oct 31, 2017 | Pro | Pro | Pro |
| Oct 31, 2016 | Pro | Pro | Pro |
| Oct 31, 2015 | Pro | Pro | Pro |
| Oct 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SS Innovations International | 16.04M |
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 200.90M |
| Northwest Biotherapeutics | 1.38M |
| American Oncology Network | 1.76B |
| Longduoduo Company | 6.01M |